quinuclidines has been researched along with oxidopamine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boggan, WO; Faught, K; Middaugh, LD | 1 |
| Cross, AJ; Waddington, JL | 1 |
| Glowinski, J; Godeheu, G; Kemel, ML; Pérez, S; Soubrié, P | 1 |
| Bianchi, C; Della Corte, L; Fantin, M; Manzalini, M; Marti, M; Morari, M | 1 |
| Bordia, T; Decker, MW; McGregor, M; McIntosh, JM; Papke, RL; Quik, M | 1 |
5 other study(ies) available for quinuclidines and oxidopamine
| Article | Year |
|---|---|
Effect of dopaminergic drugs on enhancement of the binding of quinuclidinyl benzilate by phencyclidine in vivo.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Atropine; Benzazepines; Dopamine; Dopamine Agents; Ergolines; Hydroxydopamines; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Oxidopamine; Phencyclidine; Quinpirole; Quinuclidines; Quinuclidinyl Benzilate | 1989 |
[3H] Quinuclidinyl benzylate and [3H] GABA receptor binding in rat substantia nigra after 6-hydroxy-dopamine lesions.
Topics: Animals; Corpus Striatum; gamma-Aminobutyric Acid; Hydroxydopamines; Kinetics; Male; Neural Pathways; Oxidopamine; Quinuclidines; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Cholinergic; Receptors, Dopamine; Receptors, GABA-A; Receptors, Muscarinic; Substantia Nigra | 1980 |
Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum.
Topics: Acetylcholine; Animals; Benzamides; Corpus Striatum; Dopamine; Dopamine Antagonists; Enzyme Inhibitors; In Vitro Techniques; Male; N-Methylaspartate; Neural Inhibition; Neurons; Oxidopamine; Peptide Fragments; Piperidines; Pyrrolidonecarboxylic Acid; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Tachykinin; Substance P; Synaptic Transmission; Tachykinins; Time Factors | 2002 |
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Topics: Adrenergic Agents; Animals; Benzazepines; Bicuculline; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; GABA Antagonists; Glutamic Acid; Magnesium; Male; N-Methylaspartate; Neurons; Oxidopamine; Piperidines; Potassium Chloride; Quinuclidines; Raclopride; Rats; Rats, Sprague-Dawley; Substance P; Substantia Nigra; Tetrodotoxin; Time Factors | 2005 |
The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.
Topics: Adrenergic Agents; alpha7 Nicotinic Acetylcholine Receptor; Animals; Autoradiography; Brain; Indoles; Male; Neuroprotective Agents; Nicotinic Agonists; Oxidopamine; Parkinsonian Disorders; Quinuclidines; Rats; Rats, Sprague-Dawley | 2015 |